Complement activation by model drug carriers for intravenous application: Determination by two-dimensional electrophoresis

Biomaterials

Volumn 20, Issue 21, 1999, Pages 2063-2068

  Luck M ^a   Schroder W ^a   Paulke, B R ^b   Blunk, T ^c   Muller R H ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b FRAUNHOFER INSTITUTE FOR APPLIED POLYMER RESEARCH   (Germany)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Complement activation; Drug targeting; Particulate drug carriers; Protein adsorption; Two dimensional electrophoresis

Indexed keywords

ADSORPTION; DRUG INTERACTIONS; ELECTROPHORESIS; GELS; LATEXES; PROTEINS;

COMPLEMENT ACTIVATION; PARTICULATE DRUG CARRIERS;

BIOMATERIALS;

DRUG CARRIER; LATEX;

ADSORPTION; ARTICLE; COMPLEMENT ACTIVATION; DRUG PROTEIN BINDING; ELECTROPHORESIS; IN VITRO STUDY; INTRAVENOUS ADMINISTRATION; PRIORITY JOURNAL; REACTION ANALYSIS;

ADSORPTION; COMPLEMENT ACTIVATION; COMPLEMENT C3; DRUG CARRIERS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; INJECTIONS, INTRAVENOUS; LATEX; MALE; MODELS, CHEMICAL; SURFACE PROPERTIES;

EID: 0344500892     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(99)00110-6     Document Type: Article

References (35)

1. Juliano R.L. Factors affecting the clearance kinetics and tissue distribution of liposomes, microspheres and emulsions. Adv Drug Deliv Rev. 2:1988;31-54.
2. Müller R.H., Heinemann S. Surface modelling of microparticles as parenteral systems with high tissue affinity. Gurny R., Junginger H.E. Bioadhesion - possibilities and future trends. 1989;202-213 Wissenschaftliche Verlagsgesellschaft, Stuttgart, Germany.
3. Davis S.S., Illum L., Moghimi S.M.et al. Microspheres for targeting drugs to specific body sites. J Control Rel. 24:1993;157-163.
4. Blunk T. Plasmaproteinadsorption auf kolloidalen Arzneistoffträgern. PhD thesis, University of Kiel, Germany, 1994.
5. Stolnik S., Illum L., Davis S.S. Long circulating microparticulate drug carriers. Adv Drug Deliv Rev. 16:1995;195-215.
6. Leroux J.-C., De Jaeghere F., Anner B., Doelker E., Gurny R. An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytes. Life Sci. 57:1995;695-703.
7. Leroux J.-C., Allémann E., De Jaeghere F., Doelker E., Gurny R. Biodegradable nanoparticles. from sustained release formulations to improved site specific drug delivery J Control Rel. 39:1996;339-350.
8. Scieszka J.F., Maggiora L.L., Wright S.D., Cho M.J. Role of complements C3 and C5 in the phagocytosis of liposomes by human neutrophils. Pharm Res. 8:1991;65-69.
9. Frank M.M., Fries L.F. The role of complement in inflammation and phagocytosis. Immunol Today. 12:1991;322-326.
10. Patel H.M. Serum opsonins and liposomes. their interaction and opsonophagocytosis Crit Rev Ther Drug Carr Syst. 9:1992;39-90.
11. Lück M. Plasmaproteinadsorption als möglicher Schlüsselfaktor für eine kontrollierte Arzneistoffapplikation mit partikulären Trägern. PhD thesis, The Free University of Berlin, Germany, 1997.
12. Blunk T., Hochstrasser D.F., Sanchez J.-C., Müller B.W., Müller R.H. Colloidal carriers for intravenous drug targeting: plasma protein adsorption patterns on surface-modified latex particles evaluated by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis. 14:1993;1382-1387.
13. Leroux J.-C., Gravel P., Balant L.et al. Internalization of poly(D,L-lactic acid) nanoparticles by isolated human leukocytes and analysis of plasma proteins adsorbed onto the particles. J Biomed Mater Res. 28:1994;471-481.
14. Lück M., Schröder W., Harnisch S.et al. Identification of plasma proteins facilitated by enrichment on particulate surfaces. analysis by two-dimensional electrophoresis and N-terminal microsequencing Electrophoresis. 18:1997;2961-2967.
15. Allémann E., Gravel P., Leroux J.-C., Balant L., Gurny R. Kinetics of blood component adsorption on poly(D,L-lactic acid) nanoparticles. evidence of complement C3 component involvement J Biomed Mater Res. 11:1997;229-234.
16. Paulke B.-R., Möglich P.-M., Knippel E., Budde A., Nitzsche R., Müller R.H. Electrophoretic 3D-mobility profiles of latex particles with different surface groups. Langmuir. 11:1995;70-74.
17. Kazatchkine M.D., Carreno M.P. Activation of the complement system at the interface between blood and artificial surfaces. Biomaterials. 9:1988;30-35.
18. Labarre D., Montdargent B., Carreno M.-P., Maillet F. Strategy for in vitro evaluation of the interactions between biomaterials and complement systems. J Appl Biomater. 4:1993;231-240.
19. Montdargent B., Toufik J., Carreno M.-P., Labarre D., Jozefowicz M. Complement activation and adsorption of protein fragments by functionalized polymer surfaces in human serum. Biomaterials. 13:1992;571-576.
20. Montdargent B., Maillet F., Carreno M.-P., Jozefowicz M., Kazatchkine M., Labarre D. Regulation by sulphonate groups of complement activation induced by hydroxymethyl groups on polystyrene surfaces. Biomaterials. 14:1993;203-208.
21. Pascual M., Plastre O., Montdargent B., Labarre D., Schifferli J.A. Specific interactions of polystyrene biomaterials with factor D of human complement. Biomaterials. 14:1993;665-670.
22. Toufik J., Carreno M.-P., Jozefowicz M., Labarre D. Activation of the complement system by polysaccharidic surfaces bearing carboxymethyl, carboxymethylbenzylamide and carboxymethylbenzylamide sulphonate groups. Biomaterials. 16:1995;993-1002.
23. Toufik J., Labarre D. Relationship between reduction of complement activation by polysaccharide surfaces bearing diethylaminoethyl groups and their degree of substitution. Biomaterials. 16:1995;1081-1088.
24. Hochstrasser D.F., Harrington M.G., Hochstrasser A.-C., Miller M.J., Merril C.R. Methods for increasing the resolution of two-dimensional protein electrophoresis. Anal Biochem. 173:1988;424-435.
25. Appel R.D., Hochstrasser D.F., Funk M., Vargas J.R., Pellegrini C., Muller A.F., Scherrer J.R. The MELANIE project. from a biopsy to automatic protein map interpretation by computer Electrophoresis. 12:1991;722-735.
26. Anderson N.L., Anderson N.G. A two-dimensional gel database of human plasma proteins. Electrophoresis. 12:1991;883-906.
27. Golaz O., Hughes G.J., Frutiger S.et al. Plasma and red blood cell protein maps. update 1993 Electrophoresis. 14:1993;1223-1231.
28. Bairoch A., Boeckman B. The SWISS-PROT protein sequence data bank, recent developments. Nucleic Acids Res. 21:1993;3093-3096.
29. Kinoshita T. Biology of complement. the overture Immunol Today. 12:1991;291-295.
30. Lambris J.D. The multifunctional role of C3, the third component of complement. Immunol Today. 9:1988;387-393.
31. Miura N.-H., Sano Y., Oda E.et al. Purification and characterization of a novel glycoprotein which has significant homology to heavy chains of inter-. α -trypsin inhibitor family from human plasma J Biochem. 117:1995;400-407.
32. Saguchi K., Tobe T., Hashimoto K.et al. Cloning and characterization of cDNA for inter-. α -trypsin inhibitor family heavy chain-related protein (IHRP), a novel human plasma glycoprotein J Biochem. 117:1995;14-18.
33. Nishimura H., Kakizaki I., Muta T.et al. cDNA and deduced amino acid sequence of human PK-120, a plasma kallikrein-sensitive protein. FEBS Lett. 357:1995;207-211.
34. *3 allele and its role in affecting the binding of apolipoprotein H (beta 2-glycoprotein I to anionic phospholipids. Hum Genet. 95:1995;385-388.
35. Nimpf J., Bevers E.M., Bomans P.H.et al. Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein I. Biochim Biophys Acta. 884:1986;142-149.